DHEA vs Enclomiphene
A side-by-side research comparison of DHEA and Enclomiphene across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | DHEA | Enclomiphene |
|---|---|---|
| Full name | Dehydroepiandrosterone | Enclomiphene Citrate |
| Category | Hormone Replacement | Hormone Replacement |
| Status | OTC supplement / Prescribed | Investigational drug |
| Mechanism | Serves as a precursor to both testosterone and estrogen. Also acts directly on DHEA-specific receptors, supports immune function, neurosteroid activity, and cellular metabolism. | Blocks estrogen receptors in the hypothalamus, reducing negative feedback and increasing GnRH pulsatility, which stimulates LH and FSH release for endogenous testosterone production. |
| Molecular weight | 288.42 Da | 598.09 Da |
| Half-life | 15-38 hours | 10-14 hours |
| Bioavailability | ~100% oral | ~50% oral |
| Typical dose | 25-100 mg | 12.5-25 mg |
| Frequency | Daily (morning) | Daily |
| Route | Oral capsule or topical cream | Oral capsule |
DHEA reported benefits
- Hormone precursor support
- Improved energy levels
- Bone density support
- Cognitive function
- Immune enhancement
- Anti-aging
Enclomiphene reported benefits
- Increased endogenous testosterone
- Preserved fertility
- Improved libido
- Enhanced energy and mood
- No testicular atrophy
Related comparisons
Research and educational reference only. Not medical advice.